DOW JONES21,636.78-915.39 -4.06%
S&P 5002,541.47-88.60 -3.37%
NASDAQ7,502.38-295.16 -3.79%

Wells Fargo Maintains Equal-Weight on Infinity Pharmaceuticals, Lowers Price Target to $1.5

Wells Fargo maintains Infinity Pharmaceuticals (NASDAQ:INFI) with a Equal-Weight and lowers the price target from $2.5 to $1.5.

Benzinga · 03/04/2020 13:07

Wells Fargo maintains Infinity Pharmaceuticals (NASDAQ:INFI) with a Equal-Weight and lowers the price target from $2.5 to $1.5.